Document is current
Any future updates will be listed below
-
Authors
Okekunle, Akinkunmi Paul
Lee, Heejin
Provido, Sherlyn Mae P.
Chung, Grace H.
Hong, Sangmo
Yu, Sung Hoon
Lee, Chang Beom
Lee, Jung Eun
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (2020H1D3A1A04081265, 2020H1D3A1A04081265)
Seoul National University Asia Center (0448A-2021077)
Hanmi Pharmaceutical Co., Ltd. Korea (201300000001270, 201300000001270, 201300000001270, 201300000001270)
Chong Kun Dang Pharm., Seoul, Korea (201600000000225, 201600000000225, 201600000000225, 201600000000225)
Handok Inc., Seoul, Korea.
- License Information
-
More Information
Article History
Received: 12 May 2022
Accepted: 24 June 2023
First Online: 11 July 2023
Declarations
:
: The authors declare no competing interests.
: The Institutional Review Board (IRB) of Sookmyung Women’s University, Korea, approved this study (SMWU-1311-BR-012), and all respondents provided written informed consent before participation. All procedures in this study followed the ethical standards of the IRB of Sookmyung Women’s University, Korea and the 1964 Helsinki declaration with its later amendments or comparable ethical standards.
: All respondents provided consent to publish their data, and all authors approved the final manuscript for publication.
